Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 23, 2024

SELL
$1.26 - $1.79 $621 - $882
-493 Reduced 52.73%
442 $1,000
Q4 2022

Jan 19, 2023

SELL
$1.63 - $3.52 $1,616 - $3,491
-992 Reduced 51.48%
935 $2,000
Q2 2022

Jul 13, 2022

BUY
$2.2 - $4.2 $4,239 - $8,093
1,927 New
1,927 $5,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Tsfg, LLC Portfolio

Follow Tsfg, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsfg, LLC with notifications on news.